Skip to main content
Clinical Trials/NL-OMON56549
NL-OMON56549
Not yet recruiting
Not Applicable

The influence of cognitive behavioural therapy for insomnia (CBT-I) on the pathophysiology of major depressive disorder: A pilot study - The influence of CBT-I on MDD pathophysiology

niversitair Medisch Centrum Groningen0 sites34 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Groningen
Enrollment
34
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Age 18 years or older.
  • \- Primary diagnosis for MDD (without psychotic features) based on Diagnostic
  • and Statistical Manual 5th edition (DSM\-5\) criteria ascertained by the Mini
  • International Neuropsychiatric Interview (MINI).
  • \- Co\-morbid clinical insomnia (ISI \>\= 15\)
  • \- Stable pharmacological treatment for MDD. This pertains to all medication
  • described in the clinical guideline for the treatment of MDD including
  • antidepressant monotherapy, combination therapy (i.e., multiple antidepressants
  • provided simultaneously), and augmentation therapy (i.e., antidepressants
  • combined with lithium or atypical antipsychotics). No changes in

Exclusion Criteria

  • \- Comorbid diagnoses for a psychiatric disorder within one of the following
  • diagnostic groups:
  • o Bipolar disorders
  • o Schizophrenia or other psychotic disorders
  • o Delirium, dementia, and amnestic and other cognitive disorders
  • o Substance use disorder
  • \- Current or recent (four weeks prior to inclusion) use of non\-prescribed
  • psychoactive compounds (i.e., recreational drugs, herbal medicine etc.) not
  • including caffeine and alcohol.
  • \- Pregnancy or breastfeeding.

Outcomes

Primary Outcomes

Not specified

Similar Trials